Press release
Companion Diagnostics Market to grow at a CAGR of 11.8% during the forecast period
New York, Global Companion Diagnostics Market was valued at USD 5.9 billion in 2021 and it is anticipated to grow at a CAGR of 11.8% during the forecast period to reach up to USD 18.0 billion by 2031.Global Companion Diagnostics Market report from Global Insight Services is the single authoritative source of intelligence on Companion Diagnostics Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.
Read more about Companion Diagnostics Market here: https://www.globalinsightservices.com/reports/companion-diagnostics-market/
Companion diagnostics is a medical device used along with therapeutic drugs to analyze the effect & applicability of drugs on a specific human body. Companion diagnostics are developed along with drugs for selecting or excluding groups of patients based on the characteristics of which they respond to the therapy. This device helps the healthcare professional to analyze whether a particular treatment is beneficial to the patient.
Request sample copy of this research study: https://www.globalinsightservices.com/request-sample/GIS10261/
Market Trends and Drivers
The key factor such as the growing requirement for targeted medicine is boosting the growth of the market. With advances in genetic sequencing and genomics, it is now extensively believed that drugs can show varying outcomes in different individuals. A better understanding of the genetic characteristics or biomarkers of an individual can promote the practice of administering 'the right drug, at the right time, at the right dose, for the right person. Pharmaceutical and biopharmaceutical companies are regularly attempting to implement patient-selection diagnostic frameworks in the earlier stages of drug development to provide targeted therapies to the right candidate. This further boosted the growth of the companion diagnostics market.
Get Customized Report as Per Your Requirement: https://www.globalinsightservices.com/request-customization/GIS10261/
Global Companion Diagnostics Market Segmentation
The report analyses the global companion diagnostics market based on product & services, technology, indication, end user, and region.
Based on products & services, it is segmented into assays, kits & reagents, software and services. The assay, kits & reagents accounted for the largest share of the companion diagnostics market in 2021. The factors such as the availability of a wide range of products coupled with the increasing use of assays and kits in different therapeutic areas are boosting the growth of the market.
Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. The North American region is likely to dominate the market during the forecast period. The key factors such as the presence of many leading companion diagnostic vendors & national clinical laboratories coupled with the easy accessibility to technologically advanced devices and instruments, and the highly developed healthcare system in the US and Canada.
Major Players in Companion Diagnostics Market
The key players of the companion diagnostics market are F. Hoffmann-La Roche Ltd. (Switzerland), Agilent Technologies, Inc. (US), Qiagen N.V. (Germany), Thermo Fisher Scientific, Inc. (US), Abbott Laboratories, Inc. (US), Almac Group (UK), Danaher Corporation (US), Illumina Inc. (US), bioMérieux SA (France), Myriad Genetics, Inc. (US), Sysmex Corporation (Japan), Abnova Corporation (Taiwan), Guardant Health, Inc. (US), ICON Plc (Ireland), BioGenex Laboratories, Inc. (US), Invivoscribe Technologies (US), ArcherDX, Inc. (US), NG Biotech (France), Q² Solutions (US), Amoy Diagnostics Co., Ltd. (China), Abacus Diagnostica Oy (Finland), Asuragen Inc. (US), SAGA Diagnostics (Sweden), Meso Scale Diagnostics, LLC. (US), and Creative Biolabs (US).
Purchase your copy now: https://www.globalinsightservices.com/checkout/single_user/GIS10261/
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Companion Diagnostics Market to grow at a CAGR of 11.8% during the forecast period here
News-ID: 2751068 • Views: …
More Releases from Global Insight Services

Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing …
The Immuno Oncology Drugs Market is rapidly emerging as a transformative segment in the global healthcare industry. These drugs harness the body's immune system to identify and attack cancer cells, offering innovative treatment alternatives to traditional chemotherapy and radiation therapies. Immuno-oncology therapies include monoclonal antibodies, checkpoint inhibitors, cancer vaccines, and cell-based therapies such as CAR-T cells. The growth of this market is primarily driven by advancements in biotechnology, an improved…

GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Ove …
The GLP 1 Market is experiencing unprecedented growth, fueled by the rising prevalence of type 2 diabetes and obesity globally. GLP-1, or glucagon-like peptide-1 receptor agonists, represents a groundbreaking therapeutic class that improves insulin secretion, reduces glucagon production, and slows gastric emptying. These mechanisms not only enhance glycemic control but also support weight management, making GLP-1 therapies a preferred choice among healthcare providers and patients alike. Over the years, the…

Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAG …
Market Overview
Autonomous Bus Market is revolutionizing the future of urban mobility through advanced automation technologies. Valued at $2.1 billion in 2024, the market is projected to reach $11.6 billion by 2034, expanding at a strong CAGR of 18.8%. This market focuses on the development and deployment of self-driving buses equipped with cutting-edge sensors, artificial intelligence, and vehicle-to-everything (V2X) communication systems. These buses are designed to improve road safety, enhance passenger…

Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | …
Market Overview
Automotive Tire Market is experiencing remarkable growth as the industry embraces innovation, sustainability, and digital transformation. Valued at $406 billion in 2024, the market is projected to soar to $976.7 billion by 2034, reflecting a CAGR of 9.2%. This expansion is primarily driven by the surge in global vehicle production, growing consumer preference for durable and high-performance tires, and the increasing adoption of smart tire technologies. The Automotive Tire…
More Releases for Diagnostics
Covid-19 Diagnostic Market is Booming Worldwide By Top Key Players: Abbott Diagn …
LOS ANGELES, United States: QY Research has recently published a research report titled, “Global and China Covid-19 Diagnostic Market Size, Status and Forecast 2020-2026". This report has been prepared by experienced and knowledgeable market analysts and researchers. It is a phenomenal compilation of important studies that explore the competitive landscape, segmentation, geographical expansion, and revenue, production, and consumption growth of the global Covid-19 Diagnostic market. Players can use the accurate…
What are the Growth Drivers of Covid-19 Diagnostic Market? BD Diagnostics, Abbot …
Market Study Report LLC recently added a new title on 2020-2025 Global Covid-19 Diagnostic Market Report from its database. The report provides study with in-depth overview, describing about the Product, market size, share, Industry Scope and elaborates market outlook and status to 2025.
The Covid-19 Diagnostic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact…
North America Autoimmune Disease Diagnostics Market (2020-2026) | Abbott Laborat …
According to the Graphical Research new growth forecast report titled "North America Autoimmune Disease Diagnostics Market Value By Product (Systemic Autoimmune Disease {Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus}, Localized Autoimmune Disease), Industry Analysis Report, Regional Outlook (U.S., Canada)", Estimated To Exceed USD 6.5 Billion By 2026. Autoimmune diagnostic procedures have increased demand for instruments and services for rapid and effective outcomes. Rising adoption of lab automation technology will foster…
Covid-19 Diagnostic Market Overall Study Report 2020-2026 | Abbott Diagnostics, …
This report focuses on Covid-19 Diagnostic volume and value at global level, regional level and company level. From a global perspective, this report represents overall Covid-19 Diagnostic market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
Get Free Sample PDF Copy at https://www.reportsnreports.com/contacts/requestsample.aspx?name=3095138.
Top Key Players in the Global Covid-19 Diagnostic Market Include: -
o Abbott Diagnostics
o …
Global Allergy Diagnostics Market 2020 Lincoln Diagnostics, Hitachi Chemical Dia …
Global Allergy Diagnostics Industry Competitive Analysis - Forecast and Historical Market Analysis by Key Market Segments
The research report on the global Allergy Diagnostics market encompasses a wide-scope analysis of various macro economic and micro economic factors affecting the industry performance on a regional and global level. The research report offers a detailed outline of the industry chain components including suppliers, customers, manufacturers, and distributors. Moreover, the report intends to offer…
Healthcare , Sepsis Diagnostics Market report, Sepsis Diagnostics Market size, S …
An insightful study, titled “Sepsis Diagnostics Market” has been freshly broadcasted to the vast research repository of FACT.MR. This research study provides detailed comprehensions and forecasts future growth of the global market with an in-depth study of the factors impacting revenue growth throughout the mentioned forecast period. Further, a deep analysis on the major players from diverse regions is also present in the report.
Get Sample Copy of this Report @…